Novel Insights into Molecular Mechanisms and Therapy of Soft Tissue Sarcomas

Dear Colleagues,

Soft tissue sarcomas (STSs) represent a cluster of uncommon malignant neoplasms originating from embryonic mesenchymal tissues that give rise to cartilage, muscle, blood vessels, nerves, and adipose tissue. More than 50 distinct subcategories of STSs have been identified, with certain subtypes showing a predilection for affecting children, while others predominantly affect adults. STSs exhibit substantial diversity at the cellular and genomic levels, encompassing subgroups primarily distinguished by chromosomal translocations or genetic anomalies, along with others characterized by limited genomic deviations.

In spite of recent advancements in therapeutic strategies, achieving effective local control of tumors in aggressive forms remains challenging, and the prognosis for patients with metastatic disease remains unfavorable. However, certain cutting-edge technologies have enabled the comprehensive identification of molecular mechanisms associated with different STS subtypes. Altered molecular mechanisms influenced by transcriptional, post-transcriptional or post-translational regulators have been implicated in crucial biological pathways in STSs. The identification of dysregulations at the molecular levels that confer vulnerabilities to therapeutic interventions is yielding new biomarkers and therapeutic targets, offering the potential to enhance clinical management.

This Special Issue invites submissions of high-quality original research and review articles centered on fundamental and translational research that shares insights on regulatory networks in both adult and pediatric STSs, and unveil novel mechanisms underpinning the pathogenesis and progression of STSs, ultimately offering novel avenues to enhance patient outcomes, particularly with regard to radiotherapy and drug resistance.

Dr. Matteo Cassandri
Dr. Silvia Pomella
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cells is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• soft tissue sarcoma
• molecular genetics
• epigenetics 
• gene expression 
• ncRNA 
• post-transcriptional regulations 
• post-translational modifications 
• targeted therapy 
• drug resistance 
• molecular biomarkers